UBS O'Connor’s Amgen AMGN Stock Holding History

UBS O'Connor’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,000	Closed	-$20K	–	427
2024 Q3	$20K	Buy	+10,000	New	+$3.27M	﹤0.01%	448

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS O'Connor's AMGN Position: Q3 2013 in Review

UBS O'Connor sold out of Amgen (AMGN) in Q3 2013, closing a stake of 64,000 shares — an estimated $6.31M sold.

UBS O'Connor first reported a position in AMGN in Q2 2013 and held it in 1 quarter. The position peaked at $6.31M in Q2 2013. 1,062 funds tracked by Wall St. Rank hold AMGN as of Q3 2013.

UBS O'Connor reported no remaining Amgen position as of Q3 2013 after selling out during the quarter.
UBS O'Connor sold 64,000 Amgen shares in Q3 2013, an estimated $6.31M.
UBS O'Connor first reported a position in Amgen in Q2 2013 and held it in 1 quarter.
UBS O'Connor's Amgen position peaked at $6.31M in Q2 2013.
1,062 funds tracked by Wall St. Rank held Amgen as of Q3 2013.

Based on UBS O'Connor's 13F filing for Q3 2013, filed 14 Nov 2013.